This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Reversible Posterior Leukoencephalopathy Syndrome

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Reversible Posterior Leukoencephalopathy Syndrome Means

Reversible Posterior Leukoencephalopathy Syndrome, often called PRES or RPLS, is a rare condition where parts of the brain swell, especially the back (posterior) areas. This swelling can cause symptoms such as headaches, vision changes, seizures, confusion, and weakness on one side of the body. The term "reversible" means that with proper treatment, the swelling and symptoms often improve or go away. PRES is not a disease itself but a syndrome—a group of symptoms caused by different underlying problems.

Why PRES Can Matter in Cancer Care

PRES can occur in people with various health issues, including those receiving cancer treatments. Some chemotherapy drugs and medicines that suppress the immune system may increase the risk of PRES. Cancer patients often have complex health needs, and PRES symptoms can come on quickly and be serious. Recognizing PRES early is important to prevent brain damage and to adjust cancer care safely. PRES may also be linked to other conditions common in cancer patients, such as high blood pressure, kidney problems, or infections.

What Patients Might See, Feel, or Be Told

People with PRES often develop symptoms suddenly. These can include severe headaches, seizures, vision problems like blurred vision or loss of part of the visual field, confusion, drowsiness, or weakness on one side of the body. Sometimes, difficulty speaking or extreme sleepiness may occur. These symptoms can be frightening and may require urgent medical attention. Doctors usually confirm PRES with brain imaging tests like MRI scans that show swelling in the brain.

Where You Might Encounter the Term PRES

You might see PRES mentioned in medical reports, imaging results, treatment plans, or discussions about side effects of cancer therapies. It may also appear in notes about neurological symptoms or complications during hospital stays. Because PRES has several names—Posterior Reversible Encephalopathy Syndrome, Reversible Posterior Leukoencephalopathy Syndrome, or RPLS—comparing these terms can help avoid confusion.

What PRES Does Not Automatically Mean

Seeing the term PRES does not mean permanent brain damage or that cancer is worse. PRES is often reversible with proper treatment. It also does not mean a specific cancer diagnosis or a particular treatment plan by itself. PRES is a description of a brain condition that can happen for many reasons, so it’s important not to jump to conclusions without discussing it with your healthcare providers.

Practical Questions to Ask Your Care Team

If PRES is mentioned in your care, you might ask: What caused PRES in my case? What symptoms should I watch for? How will it affect my cancer treatment or recovery? What treatments will be used to manage PRES? When should I seek urgent care? Understanding these points can help you feel more in control and prepared.

How to Read PRES in Context

Because PRES can appear under different names, it helps to compare the wording in your reports and ask your care team to explain what it means for you. The term alone does not decide your treatment or outcome. It’s important to understand how PRES fits into your overall health and care plan.

Safety and Next Steps

This information is meant to help you understand PRES but does not replace medical advice. Each person’s health situation is unique. If PRES appears in your medical records or care discussions, the best next step is to talk with your healthcare team about what it means for you, how it affects your treatment, and what symptoms to report. Early recognition and treatment of PRES can improve outcomes and help keep your care on track.

Sources

Public source information used for this glossary entry includes: